GCP/GLP/GMP Expertise Quinta-Analytica is a fully in-house CRO with GCP, GLP, GMP certifications and EMA/FDA inspections, indicating robust compliance and high-quality reliability for outsourced clinical testing, bioanalysis, quality control, and CMC support—a strong value proposition for pharma and biotech partners seeking validated capabilities.

Expanded Clinical Capacity With two in-house clinical units offering BE/BA/PK studies and bed capacity of 60+36, Quinta can accommodate mid-scale clinical trials, enabling potential clients to streamline development timelines and consolidate services under one provider.

Biologics and Biosimilars Focus The portfolio covers small molecules, biologics, biosimilars, and cell-based assays, plus specialized QA for biologics and impurities studies, creating cross-sell opportunities with clients advancing biologics and biosimilar programs.

Regulatory Readiness FDA inspections, EMA alignment, and end‑to‑end support from preclinical through regulatory submission and market release position Quinta as a trusted partner for global regulatory readiness and robust data packages.

UHPLC Capability Recent addition of UHPLC toolset signals continued investment in advanced analytics, enabling higher resolution and faster turnaround for analytical testing, which can attract clients needing cutting-edge bioanalytical and impurity profiling services.